BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33955407)

  • 1. An Insight Into the Driver Mutations and Molecular Mechanisms Underlying Mucinous Adenocarcinoma of the Rectum.
    Reynolds IS; O'Connell E; Fichtner M; Blümel A; Mason SE; Kinross J; McNamara DA; Kay EW; O'Connor DP; Das S; Burke JP; Prehn JHM
    Dis Colon Rectum; 2021 Jun; 64(6):677-688. PubMed ID: 33955407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression.
    Duggan WP; Kisakol B; O'Connell E; Matveeva A; O'Grady T; McDonough E; Lindner AU; McNamara D; Longley D; Ginty F; Burke JP; Prehn JHM
    Dis Colon Rectum; 2023 Jul; 66(7):914-922. PubMed ID: 36525395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
    Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
    Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role for Primary Tumor Location in Patients With Colorectal Liver Metastases: A Comparison of Right-Sided Colon, Left-Sided Colon, and Rectum.
    Takamizawa Y; Shida D; Horie T; Tsukamoto S; Esaki M; Shimada K; Kondo T; Kanemitsu Y
    Dis Colon Rectum; 2023 Feb; 66(2):233-242. PubMed ID: 35714342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
    O'Brien SJ; Kalbfleisch T; Srivastava S; Pan J; Rai S; Petras RE; Ronquillo N; Polk HC; Galandiuk S
    Dis Colon Rectum; 2021 Sep; 64(9):1083-1095. PubMed ID: 33990498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
    Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Clinicopathological Characteristics of Appendiceal Tumors in Japan: A Multicenter Collaborative Retrospective Clinical Study- A Japanese Nationwide Survey.
    Matsui S; Murata K; Fukunaga Y; Takeda T; Fujii M; Yamaguchi T; Kagawa Y; Mizushima T; Ohno Y; Yao T; Doki Y; Sugihara K
    Dis Colon Rectum; 2020 Oct; 63(10):1403-1410. PubMed ID: 32969883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
    Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
    Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
    Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
    Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MKI67, TPR , and TCHH Mutations as Prognostic Biomarkers for Patients With Defective Mismatch Repair Colon Cancer Stage II/III.
    Lv J; Li W; Wang X; Guo L; Wang D; Zhang Y; Yu J; Chen T; Niu B; Wang X; Liu Z
    Dis Colon Rectum; 2023 Nov; 66(11):1481-1491. PubMed ID: 37643197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
    Izquierdo KM; Humphries MD; Farkas LM
    Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.